EyePoint, Inc.·4

Jan 6, 4:47 PM ET

Ribeiro Ramiro 4

4 · EyePoint, Inc. · Filed Jan 6, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Ribeiro Ramiro
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-03+19,66719,667 total
  • Tax Payment

    Common Stock

    2026-01-03$17.48/sh6,373$111,40013,294 total
  • Award

    Restricted Stock Units

    2026-01-02+85,70085,700 total
    Exercise: $0.00Common Stock (85,700 underlying)
  • Award

    Stock Option (Right to Buy)

    2026-01-02+171,400171,400 total
    Exercise: $17.48Exp: 2036-01-02Common Stock (171,400 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2026-01-0319,66739,333 total
    Exercise: $0.00Common Stock (19,667 underlying)
Footnotes (4)
  • [F1]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
  • [F2]The restricted stock units will vest in three ratable annual installments beginning January 2, 2027.
  • [F3]The option to purchase will vest and become exercisable as follows: 25% at January 2, 2027 and the remainder ratably, on a monthly basis, over the remaining three years.
  • [F4]The restricted stock units vest in three ratable annual installments beginning January 3, 2026.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT